Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies
Induction of broadly neutralising antibodies (bnAbs) capable of inhibiting infection with diverse variants of human immunodeficiency virus type 1 (HIV-1) is a key, as-yet-unachieved goal of prophylactic HIV-1 vaccine strategies. However some HIV-infected individuals develop bnAbs after ~2-4 years of...
Hlavní autoři: | Borrow, P, Moody, M |
---|---|
Médium: | Journal article |
Vydáno: |
Wiley
2017
|
Podobné jednotky
-
Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
Autor: Moody, M, a další
Vydáno: (2016) -
Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
Autor: Elise Landais, a další
Vydáno: (2018-09-01) -
Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies against HIV-1
Autor: Lei eYu, a další
Vydáno: (2014-06-01) -
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Autor: Haynes, BF, a další
Vydáno: (2022) -
Broadly Neutralizing Antibody Responses in a Subset of HIV-1-Infected Individuals in Chennai, India
Autor: Syed Iqbal Hussain PhD, a další
Vydáno: (2017-03-01)